Mastocytoma in the horse
Häni, H.; von Tscharner, C.
Schweizer Archiv für Tierheilkunde 121(5): 269-272
1979
ISSN/ISBN: 0036-7281 PMID: 109918 Document Number: 141298
Document emailed within 1 workday
Related Documents
Steenbergen, M. 2013: The Horse Symptom Prevention Packet (Triple P): a preventive membership in the horse husbandry Tijdschrift voor diergeneeskunde 138(5): 301-303Braun, U.; Förster, M.; Schams, D. 1984: Intersexuality in the horse. Morphologic, hormone analytic and cytogenetic studies in an Arabohaflinger horse Tierarztliche Praxis 12(3): 342-349
Boissevain, I. 2014: Owner of a horse is legally responsible if the horse kicks the stable manager Tijdschrift Voor Diergeneeskunde 139(6): 43
Scheler, W.; Schoffa, G.; Jung, F. 1957: Light absorption and paramagnetic susceptibility of the derivatives of horse and Chironomus methemoglobins and of horse metmyoglobin Biochemische Zeitschrift 329(3): 232-246
Slivinska, K. 2006: The gastro-intestinal parasites community of the Przewalski's horse, Equus przewalskii Poljakov, 1881, and the domestic horse in the Chernobyl exclusion zone Wiadomosci Parazytologiczne 52(1): 55-58
Nevole, M.; Halouzka, R.; Cerný, L. 1972: Cutaneous mastocytoma in dogs Veterinarni Medicina 17(1): 33-38
Jain, V.K.; Dayal, S. 1997: Solitary mastocytoma in an adult Indian Journal of Dermatology Venereology and Leprology 63(5): 310-311
Isenbugel, E. 2002: From wild horse to riding horse Schweizer Archiv für Tierheilkunde 144(7): 323-329
Massey, P. 1989: Gift horse or Trojan horse? Nursing Times 85(10): 49
Palungwachira, P.; Yaguchi, H.; Palungwachira, P. 2004: Electron microscopic study in a case of solitary mastocytoma Journal of the Medical Association of Thailand 87(5): 561-566
Cohen, M.C.; Zeschke, R.; Bigazzi, P.E.; Yoshida, T.; Cohen, S. 1975: Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants Journal of Immunology 114(5): 1641-1643
Phillips, M.J.; Gold, W.M.; Goetzl, E.J. 1983: IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells Journal of Immunology 131(2): 906-910
Takei, F.; Levy, J.G.; Kilburn, D.G. 1977: Characterization of suppressor cells in mice bearing syngeneic mastocytoma Journal of Immunology 118(2): 412-417
Taurog, J.D.; Mendoza, G.R.; Hook, W.A.; Siraganian, R.P.; Metzger, H. 1977: Noncytotoxic IgE-mediated release of histamine and serotonin from murine mastocytoma cells Journal of Immunology 119(5): 1757-1761
Komatsu, K.; Nakamura, W. 1986: Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432 Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 180(1): 117-120
Nakamura, W.; Nishimoto, Y. 1972: Urinary 5-hydroxyindoleacetic acid as an indicator of the in vivo growth of mastocytoma cells Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 166(8): 1182-1188
Barr, M.C.; Butt, M.T.; Anderson, K.L.; Lin, D.S.; Kelleher, T.F.; Scott, F.W. 1993: Spinal lymphosarcoma and disseminated mastocytoma associated with feline immunodeficiency virus infection in a cat Journal of the American Veterinary Medical Association 202(12): 1978-1980
Bukhari, I.A. 2004: Solitary mastocytoma successfully treated with a moderate potency topical steroid Journal of Drugs in Dermatology: Jdd 3(3): 309-310
Nagy, E.; Baral, E.; Kangas, L.; Berczi, I. 1997: Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes Anticancer Research 17(2a): 1083-1088
Baral, E.; Nagy, E.; Kangas, L.; Berczi, I. 1997: Combination immunotherapy of the P815 murine mastocytoma with killer cells, IL-2 and anti-estrogens Anticancer Research 17(5a): 3653-3658